Jul 2026· Journal of Medicinal Chemistry· Vol 69, pp. 17961 - 17973· 0 citations· 63 references
Medicine
TL;DR
Scaffold-Guided Structure Refinement is presented, leveraging information on known binders within ligand series targeting a specific protein, based on the observation that shared molecular scaffolds among binders exhibit conserved binding modes.
Abstract
Efficient structure-based drug design relies on knowledge of a ligand’s binding pose and its specific interactionsinformation that is often not available experimentally. Despite the plethora of binding mode prediction methodsincluding cofoldingachieved accuracies are often insufficient. Here, we present “Scaffold-Guided Structure Refinement”, leveraging information on known binders within ligand series targeting a specific protein. Our method is based on the observation that shared molecular scaffolds among binders exhibit conserved binding modes. By applying molecular docking to diverse target model conformations, we identify those simultaneously allowing consistent scaffold placement, favorable interactions and low ligand strain. We demonstrate this approach’s ability to optimize models from different initial sourcesincluding an inaccurate cofolding modelin three case studies. In all cases, we successfully identified critical induced fit effects and accurately reconstructed near-native ligand binding modes with scaffold root-mean-square deviation (RMSD) values of at most 2.2 Å.
Assessment of pose prediction methods when the bound structure of a reference ligand is known and the likely binding mode(s) of a related compound are needed, and this work focuses on cases where the new compound has multiple potential binding modes.
Ažbeta Kubincová, S. S. Çınaroğlu, Jianna Ongsioco et al.· Journal of Chemical Informat...· 0 citations
This chapter describes a structure-based computational approach to perform high-throughput ligand screens of chemical libraries using open-source software programs and illustrates this workflow with the enzymatic molecular target NAD(P)H:quinone oxidoreductase1 (NQO1), which is overexpressed in a number of human solid...
Audrey G. Fikes, Melissa C. Srougi· Methods in molecular biology· 0 citations
A category-stratified, statistically powered benchmark comparing pose prediction from receptor conformational ensembles against AlphaFold2, used as a matched static-structure baseline, across 29 protein–ligand systems spanning cryptic-pocket, induced-fit, water-mediated, and autoimmune-indication target classes is pres...
Ryan Varghese, Pooja Tiwary, Krishil Oswal· bioRxiv· 0 citations
This work introduces a method to smoothly transition from physics-based to knowledge-based predictions based on the uncertainty of each model and shows that combining structure-based and ML models significantly improves the prediction accuracy if training data is limited, whereas the weighting smoothly shifts from dock...
Ažbeta Kubincová, David L. Mobley· Journal of Chemical Informat...· 1 citation
A four-tiered computational benchmarking study evaluating five engines against a panel of 36 compounds targeting β-secretase 1, a validated Alzheimer’s disease target with extensive co-crystal ground truth, characterized what each engine contributes independently and where RevFEP delivers signals no other engine achiev...
Kristoffer Alejo, Christopher Korban, Christian Chung· bioRxiv· 0 citations
HydroDock is extended to challenging targets with open binding pockets, populated by highly mobile water molecules that are the most troublesome for drug design, and improved docking accuracy with increases of 28% (10%) in median structural (and ranking) performance.
Bayar Bayarsaikhan, C. Hetényi, B. Z. Zsidó· ACS Physical Chemistry Au· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.